OncBioMune Acquires Propolis Product Line for German Partner

(Marketwired - July 20, 2017) - OncBioMune Pharmaceuticals, Inc. (otcqb:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, a proprietary cancer vaccine technology and commercialization of a portfolio of products internationally, is pleased to announce the acquisition of the rights to six Aagaard® Propolis products for the Mexican markets from the Company's German partner roha Arzneimittel GmbH ("roha"). OncBioMune has begun the process to market the products across Mexico, with expectations for an official launch during the fourth quarter of 2017...